Covington & Burling and Troutman Pepper Hamilton Sanders advised Quikrete Holdings, Inc. on the transaction, and Davis Polk & Wardwell advised Summit Materials, Inc. Quikrete Holdings,...
Quikrete’s $11.5 Billion Acquisition of Summit Materials
Hornblower’s Chapter 11 Filing and DIP Financing
Paul Weiss Rifkind Wharton & Garrison advised Hornblower Group on the deal and Porter Hedges served as co-counsel, while Davis Polk & Wardwell advised Crestview Advisors,...
Ferrara Candy’s Acquisition of Jelly Belly Candy
Davis Polk & Wardwell is advising Ferrara Candy Company on the transaction, and Foley & Lardner is advising Jelly Belly Candy Company. Ferrara Candy Company announced...
Kohlberg’s Acquisition of Majority Stake in Engage PEO
Davis Polk & Wardwell advised Engage PEO and Lightyear Capital, while Ropes & Gray advised Kohlberg on the transaction. Kohlberg & Company, LLC (“Kohlberg”) announced a...
ExxonMobil’s $4.9 Billion Acquisition of Denbury
Davis Polk & Wardwell is advising Exxon Mobil Corporation in the transaction. Exxon Mobil Corporation (NYSE: XOM) announced it has entered into a definitive agreement to acquire...
Crestview’s Strategic Investment in The Gersh Agency
Davis Polk advised Crestview, and Sidley Austin advised Gersch. Leading talent agency, The Gersh Agency has partnered with New York-based private equity firm Crestview Partners as a strategic...
BDT Capital Partners’ Take-Private Acquisition of Weber
Davis Polk & Wardwell advised Weber, while Cravath, Swaine & Moore advised BDT. BDT Capital Partners LLC (“BDT”) and Weber Inc. (“Weber”), a global leader in...
Ferrero Group’s Acquisition of Wells Enterprises
UBS Investment Bank acted as exclusive financial advisor and McDermott Will & Emery LLP served as legal counsel to Wells. Morgan Stanley & Co. International plc...
Novo Nordisk’s $1.1 Billion Acquisition of Forma Therapeutics
Davis Polk advised Novo Nordisk on the deal while Goodwin Procter represented Forma Therapeutics. Novo Nordisk announced its approximately $1.1 billion acquisition of Forma Therapeutics. Under the...
Cerity Partners’ Recapitalization
Davis Polk & Wardwell advised Cerity Partners and Lightyear Capital, while Willkie Farr & Gallagher advised Genstar on the deal. Lowenstein represented Cerity Partners EOE LLC....
Brookfield’s $8.3 Billion Acquisition of CDK Global
Davis Polk & Wardwell represented Brookfield, while Paul, Weiss, Rifkind, Wharton & Garrison represented CDK Global in the transaction. CDK Global, Inc., a leading automotive retail...
Charles River Laboratories’ $295 Million Acquisition of Explora BioLabs Holdings
Davis Polk advised Charles River Laboratories International on the deal. Charles River Laboratories International, Inc. announced its $295 million acquisition of Explora BioLabs Holdings, Inc. Charles...